[1] NORDON I M,HINCHLIFFO R J,LOFLUS I M,et al.Pathophysiology and epidemiology of abdominal aortic aneurysms[J].Nat Rev Cardiol,2011,8:92-102.
[2] OZASA Y,AKAZAWA H,QIN Y,et al.Notch activation mediates angiotensinⅡ-induced vascular remodeling by promoting the proliferation and migration of vascular smooth muscle cells[J].Hypertens Res,2013,36:859-865.
[3] PIGGOTT K,DEN J,WARRINGTON K,et al.Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis[J].Circulation,2011,123(3):309-318.
[4] ZHENG Y H,LI F D,TIAN C,et al.Notch γ-secretase inhibitor dibenzazepine attenuates angiotensin Ⅱ-induced abdominal aortic aneurysm in ApoE knockout mice by multiple mechanisms[J].PLoS One,2013,8(12):e83310.
[5] ACHARYA A,HANS C P,KOEIG S N,et al.Inhibitory role of Notch l in calcific aortic valve disease[J].PLoS One,2011,6:e27743.
[6] FIUZA U M,ARIAS A M.Cell and molecular biology of Notch[J].J Endocrinol,2007,194(3):459-474.
[7] SATOH H,NAKAMURA M,SATOH M,et al.Expression and localization of tumor necrosis factor-alpha and its converting enzyme in human abdominal aortic aneurysm[J].Clin Sci,2004,106(3):301-306.
[8] AOYAMA T,TAKESHITA K,KIKUCHI R,et al.γ-Secretase inhibitor reduces diet-induced atherosclerosis in apolipoprotein E-deficient mice[J].Biochem Biophys Res Commun,2009,383(2):216-221.
[9] KANEKO H,ANZAI T,HORIUCHI K,et al.Tumor necrosis factor-α converting enzyme is a key mediator of abdominal aortic aneurysm development[J].Atherosclerosis,2011,218(2):470-478.
[10] HANS C P,KOENIG S N,HUANG N,et al.Inhibition of Notch1 signaling reduces abdominal aortic aneurysm in mice by attenuating macrophage-mediated inflammation[J].Arterioscler Thromb Vasc Biol,2012,32(12):3012-3023. |